Target intelligence / Profile preview

RAB5C, member RAS oncogene family pseudogene 1 (RAB5CP1)

Target
RAB5CP1
Molecular classification
Other (Pseudogene)
01

Overview

RAB5CP1 is classified as a pseudogene, specifically annotated as "RAB5C, member RAS oncogene family pseudogene 1." Pseudogenes are DNA sequences similar to known genes but are generally nonfunctional due to mutations, truncations, or lack of regulatory elements, and therefore do not produce functional proteins[1][4][8]. Most human pseudogenes, including RAB5CP1, have no known biological function or disease relevance[4][8]. In certain rare cases, some pseudogenes may demonstrate regulatory RNA roles, but there is no evidence that RAB5CP1 has any such function. Clarification and Caution: - RAB5CP1 is often confused with RAB5C, member RAS oncogene family (RAB5C), a functional small GTPase involved in vesicular trafficking and implicated in cancer[2][3][10]. - RAB5CP1 does not encode a functioning GTPase and is not a therapeutic target. Summary: RAB5CP1 is a pseudogene; it is not an active gene, protein, or receptor and has no established function, disease link, druggability, or biomarker value[1][4][8]. Any reference to therapeutic or mechanistic roles relates to its parent gene, RAB5C, not to RAB5CP1. If you require information about the active RAB5C protein (which is a target), specify “RAB5C, member RAS oncogene family (RAB5C),” not the pseudogene RAB5CP1.

02

Mechanism of action

None

03

Biological functions

None established for RAB5CP1 (as a pseudogene)
04

Disease associations

None for RAB5CP1 specifically; the protein-coding RAB5C gene (not RAB5CP1) is implicated in cancer and other pathways[2][3].

Beyond the preview

Go deeper on RAB5C, member RAS oncogene family pseudogene 1 (RAB5CP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RAB5C, member RAS oncogene family pseudogene 1 (RAB5CP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call